Linda Evangelista Makes Rare Public Appearance After Revealing Cosmetic Procedure Left Her 'Permanently Deformed'

  • Oops!
    Something went wrong.
    Please try again later.

It’s been almost a year since supermodel Linda Evangelista went public with her lawsuit against Zeltiq Aesthetics, the parent company of the CoolSculpting fat-reducing cosmetic surgery procedure that reportedly left her “disfigured.” The 57-year-old star has stayed largely out of the public eye for the last six years because she developed Paradoxical Adipose Hyperplasia, which is a hardening of localized fat.

Even after undergoing two corrective surgeries, which did not help the issue, Evangelista revealed she fell into depression and became a “recluse.” Earlier this year, she gave People magazine an exclusive look at her body now because she was “done hiding” and no longer wanted to live with the shame. Even though she came forward, the fashionista has kept a relatively low profile since then.

More from SheKnows

On Wednesday, she was spotted in New York City in a rare public outing, but we hope that this is the start of her comeback. (See the photos HERE.) She looks fabulous with her makeup-free face and her hair pulled back while out enjoying a day in Manhattan. Evangelista kept it casual with a denim shirt, black pants, and the ultra-comfy footwear du jour, Birkenstocks. It looked like she was having a conversation on the phone while the photos were snapped, but she appeared peaceful and happy in the images.

Click here to read the full article.

With so many of her fellow supermodel colleagues still working in the industry, let’s hope this is a sign that Evangelista might be open to a return to the runway. Or, perhaps continuing to share her tale because it’s a great reminder to love the body we are in — and her story is a powerful one.

Before you go, click here to see more moms who’ve opened up about their plastic surgery procedures.

Launch Gallery: These Famous '90s Supermodels Are All Moms Now

Sign up for SheKnows' Newsletter.
For the latest news, follow us on Facebook, Twitter, and Instagram.